CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

(–)-trans-Cannabidiol, API isolate

(–)-trans-Cannabidiol, API isolate

Product Description

Active Pharmaceutical IngredientPh.Eur. 3151
Subsatnce Origin: Cannabis Sativa L.
Certifications: Czech Medicines Agency (SUKL.cz), ISO 9001:2015, ISO 14001:2015

CBDepot

CBDepot

SK
2017

On CPHI since
2

Certificates
25 - 49

Employees

Company types

Distributor/Import Export

Compare Add to favorites Added to favorites

Specifications

CAS Registry Number

13956-29-1
Selling Points
Reputation
Supplied from

Czech Republic
Measured In
kilogram

Sales Markets

Oceania
North America (USA, Canada)
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

CBDepot

CBDepot

SK
2017

On CPHI since
2

Certificates
25 - 49

Employees

Company types

Distributor/Import Export

Compare Add to favorites Added to favorites

More Products from CBDepot (2)

Product (–)-trans-Cannabidiol, PhG isolate

Pharma-GradeSubstance origin: Cannabis sativa L.
Conforms with quality criteria: DAC/NRF 2020/2, C - 052
Certifications: Czech Medicines Agency (SUKL.cz), ISO 9001:2015, ISO 14001:2015

Compare
Product (–)-trans-Cannabidiol, PhG synthesized

Pharma Grade, Active substance for pharmaceutical use.
Substance origin: chemical synthesis
Conforms with quality criteria: DAC/NRF 2016/2, C-052

Compare

CBDepot resources (2)

News CBDepot launches the sale of synthesized pharma-grade CBD

CBDepot group starts the marketing of synthesized pharma-grade CBD produced under the EU GMP umbrella of its sister company CB21 Pharma, s.r.o.

25 Oct 2021
Whitepaper CB21 Pharma, the spin-off sister company to CBDepot, successfully extends EU GMP certification to broaden its cannabis-derived active pharmaceutical ingredients (API) portfolio.

CB21 Pharma, a leading Czech-based pharmaceutical company specializing in producing cannabinoid ingredients and medical devices, has successfully extended its EU Good Manufacturing Practice (GMP) certification under certificate # sukls105303/2023. This achievement allows CB21 Pharma, the spin-off sister company to pioneering CBDepot, to continue manufacturing Active Pharmaceutical Ingredients (APIs) such as Cannabidiol (CBD), from initial extraction to the production of full spectrum distilled and standardized extracts from medicinal cannabis, marketed as Cannabis Extractum Raffinatum and Cannabis Extractum Normatum.